MiRNA‐516a promotes bladder cancer metastasis by inhibiting MMP9 protein degradation via the AKT/FOXO3A/SMURF1 axis

BACKGROUND: Metastasis is the leading cause of death in patients with bladder cancer (BC). However, current available treatments exert little effects on metastatic BC. Moreover, traditional grading and staging have only a limited ability to identify metastatic BC. Accumulating evidence indicates tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yuanyuan, Jin, Honglei, Li, Hongyan, Ma, Jiugao, Zheng, Zhijian, Sun, Binuo, Lyu, Yiting, Lin, Mengqi, Zhao, He, Shen, Liping, Zhang, Ruirui, Wu, Shuilian, Lin, Weiwei, Lu, Yongyong, Xie, Qipeng, Zhang, Gang, Huang, Xing, Huang, Haishan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752166/
https://www.ncbi.nlm.nih.gov/pubmed/33377649
http://dx.doi.org/10.1002/ctm2.263

Ejemplares similares

Ejemplares similares